Taysha Gene Therapies (TSHA) Financials: Revenue & Earnings
TSHA$4.26+0.01 +0.27%
$1.38B
Market Cap
—
P/E
—
Forward P/E
—
Score
Taysha Gene Therapies (TSHA) Financials: Revenue & Earnings
TSHA price $4.26 +0.01 +0.27%
- Ticker
- TSHA
- Price
- $4.26
- Change
- +0.01 +0.27%
- Market cap ?
- $1.38B
- Beta ?
- 1.17
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
TSHA fair value $7.43. Price $4.26. Price is 43% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.21M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.75% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 324.86M. Net debt -301.60M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.13 | — | 755.56K |
| 2026-08-11 | -0.13 | -0.11 | — | 680.00K |
| 2026-05-06 | -0.12 | -0.10 | — | 755.56K |
| 2026-03-19 | -0.08 | -0.11 | 5.48M | 2.24M |
| 2025-11-04 | -0.09 | -0.09 | — | 1.89M |
| 2025-08-12 | -0.09 | -0.07 | 1.99M | 1.73M |
| 2025-05-15 | -0.08 | -0.08 | 2.30M | 1.08M |
| 2025-02-26 | -0.07 | -0.08 | 2.02M | 2.05M |
| 2024-11-13 | -0.09 | -0.08 | 1.79M | 2.05M |
| 2024-08-12 | -0.09 | -0.10 | 1.11M | 2.66M |
| 2024-05-14 | -0.10 | -0.11 | 3.41M | 2.56M |
| 2024-03-19 | 0.35 | -0.09 | 3.60M | 2.65M |
| 2023-11-14 | -0.13 | -0.17 | 4.75M | 2.33M |
| 2023-08-14 | -0.38 | -0.31 | 2.40M | 1.05M |
| 2023-05-11 | -0.28 | -0.35 | 4.71M | 70.00K |
| 2023-03-28 | -0.99 | -0.41 | 2.50M | 8.18M |
| 2022-11-08 | -0.64 | -0.89 | — | — |
| 2022-08-11 | -0.84 | -1.05 | — | — |
| 2022-05-16 | -1.31 | -1.04 | — | — |
| 2022-03-31 | -1.32 | -1.21 | — | — |
| 2021-11-10 | -1.35 | -1.02 | — | — |
| 2021-08-16 | -1.09 | -0.81 | — | — |
| 2021-05-11 | -0.87 | -0.54 | — | — |
| 2021-03-03 | -1.04 | -0.37 | — | — |
| 2020-11-12 | -1.28 | -0.17 | — | — |
| 2020-09-25 | -0.09 | — | — | — |
| 2020-06-30 | -0.15 | — | — | — |
| 2019-12-31 | -0.02 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Nagendran Sukumar | Sell | 200.00K | $6.24 | 1.25M |
| 2026-06-01 | Stalfort John A III | Buy | 21.34K | — | — |
| 2026-06-01 | Stalfort John A III | Buy | 42.67K | $5.97 | 254.75K |
| 2026-06-01 | Donenberg Phillip B. | Buy | 21.34K | — | — |
| 2026-06-01 | Donenberg Phillip B. | Buy | 42.67K | $5.97 | 254.75K |
| 2026-06-01 | Long Alison S | Buy | 21.34K | — | — |
| 2026-06-01 | Long Alison S | Buy | 42.67K | $5.97 | 254.75K |
| 2026-06-01 | Sepp-Lorenzino Laura | Buy | 21.34K | — | — |
| 2026-06-01 | Sepp-Lorenzino Laura | Buy | 42.67K | $5.97 | 254.75K |
| 2026-04-10 | Nagendran Sukumar | Buy | 19.02K | $1.71 | 32.53K |
| 2026-04-10 | Nagendran Sukumar | Sell | 200.00K | $4.46 | 892.00K |
| 2026-04-10 | Nagendran Sukumar | Sell | 19.02K | $1.71 | 32.53K |
| 2026-02-04 | Alam Kamran | Sell | 1.66K | $4.52 | 7.48K |
| 2026-01-26 | Nagendran Sukumar | Sell | 26.92K | $4.61 | 124.09K |
| 2026-01-26 | Nolan Sean P. | Sell | 41.31K | $4.61 | 190.45K |
| 2026-01-26 | Alam Kamran | Sell | 23.85K | $4.61 | 109.94K |
| 2026-01-23 | Nagendran Sukumar | Sell | 89.13K | $4.75 | 423.38K |
| 2026-01-23 | Nolan Sean P. | Sell | 136.79K | $4.75 | 649.75K |
| 2026-01-23 | Alam Kamran | Sell | 78.97K | $4.75 | 375.10K |
| 2026-01-12 | Alam Kamran | Buy | 359.00K | — | — |
| 2026-01-12 | Alam Kamran | Buy | 231.00K | $4.86 | 1.12M |
| 2026-01-12 | Nolan Sean P. | Buy | 1.01M | — | — |
| 2026-01-12 | Nolan Sean P. | Buy | 648.00K | $4.86 | 3.15M |
| 2026-01-12 | Nagendran Sukumar | Buy | 427.00K | — | — |
| 2026-01-12 | Nagendran Sukumar | Buy | 88.68K | $1.71 | 151.64K |
| 2026-01-12 | Nagendran Sukumar | Buy | 111.32K | $0.70 | 77.80K |
| 2026-01-12 | Nagendran Sukumar | Sell | 200.00K | $4.71 | 942.00K |
| 2026-01-12 | Nagendran Sukumar | Sell | 88.68K | $1.71 | 151.64K |
| 2026-01-12 | Nagendran Sukumar | Buy | 274.00K | $4.86 | 1.33M |
| 2026-01-12 | Nagendran Sukumar | Sell | 111.32K | $0.70 | 77.80K |
| 2025-12-01 | Nagendran Sukumar | Buy | 260.05K | $1.71 | 444.68K |
| 2025-12-01 | Nagendran Sukumar | Sell | 260.05K | $4.51 | 1.17M |
| 2025-12-01 | Nagendran Sukumar | Sell | 260.05K | $1.71 | 444.68K |
| 2025-11-28 | Nagendran Sukumar | Buy | 39.95K | $1.71 | 68.32K |
| 2025-11-28 | Nagendran Sukumar | Buy | 70.17K | $0.70 | 49.04K |
| 2025-11-28 | Nagendran Sukumar | Sell | 110.12K | $4.75 | 523.09K |
| 2025-11-28 | Nagendran Sukumar | Sell | 39.95K | $1.71 | 68.32K |
| 2025-11-28 | Nagendran Sukumar | Sell | 70.17K | $0.70 | 49.04K |
| 2025-09-10 | Nagendran Sukumar | Buy | 41.15K | $0.70 | 28.76K |
| 2025-09-10 | Nagendran Sukumar | Sell | 200.00K | $3.23 | 646.00K |
| 2025-09-10 | Nagendran Sukumar | Sell | 41.15K | $0.70 | 28.76K |
| 2025-08-21 | Nagendran Sukumar | Sell | 57.05K | $2.85 | 162.60K |
| 2025-08-21 | Alam Kamran | Sell | 54.49K | $2.85 | 155.30K |
| 2025-06-02 | Stalfort John A III | Buy | 56.62K | — | — |
| 2025-06-02 | Stalfort John A III | Buy | 113.25K | $2.79 | 315.39K |
| 2025-06-02 | Donenberg Phillip B. | Buy | 56.62K | — | — |
| 2025-06-02 | Donenberg Phillip B. | Buy | 113.25K | $2.79 | 315.39K |
| 2025-06-02 | Long Alison S | Buy | 113.25K | $2.79 | 315.39K |
| 2025-06-02 | Long Alison S | Buy | 56.62K | — | — |
| 2025-06-02 | Sepp-Lorenzino Laura | Buy | 113.25K | $2.79 | 315.39K |
| 2025-06-02 | Sepp-Lorenzino Laura | Buy | 56.62K | — | — |
| 2025-05-30 | Manning Paul B | Buy | 750.00K | $2.75 | 2.06M |
| 2025-03-11 | Alam Kamran | Sell | 29.84K | $1.69 | 50.43K |
| 2025-01-02 | Nolan Sean P. | Buy | 892.50K | — | — |
| 2025-01-02 | Nolan Sean P. | Buy | 892.50K | $1.85 | 1.65M |
| 2025-01-02 | Nagendran Sukumar | Buy | 324.50K | — | — |
| 2025-01-02 | Nagendran Sukumar | Buy | 324.50K | $1.85 | 600.33K |
| 2025-01-02 | Alam Kamran | Buy | 431.00K | — | — |
| 2025-01-02 | Alam Kamran | Buy | 431.00K | $1.85 | 797.35K |
| 2024-06-27 | Manning Paul B | Buy | 1.33M | $2.25 | 3.00M |
| 2024-05-29 | Stalfort John A III | Buy | 49.22K | — | — |
| 2024-05-29 | Stalfort John A III | Buy | 98.44K | $3.17 | 312.05K |
| 2024-05-29 | Long Alison S | Buy | 98.44K | $3.17 | 312.05K |
| 2024-05-29 | Long Alison S | Buy | 49.22K | — | — |
| 2024-05-29 | Donenberg Phillip B. | Buy | 49.22K | — | — |
| 2024-05-29 | Donenberg Phillip B. | Buy | 98.44K | $3.17 | 312.05K |
| 2024-05-29 | Sepp-Lorenzino Laura | Buy | 98.44K | $3.17 | 312.05K |
| 2024-05-29 | Sepp-Lorenzino Laura | Buy | 49.22K | — | — |
| 2024-02-02 | Alam Kamran | Sell | 1.29K | $1.51 | 1.94K |
| 2024-01-02 | Alam Kamran | Buy | 590.41K | — | — |
| 2024-01-02 | Alam Kamran | Buy | 590.41K | $1.71 | 1.01M |
| 2024-01-02 | Nagendran Sukumar | Buy | 863.62K | — | — |
| 2024-01-02 | Nagendran Sukumar | Buy | 863.62K | $1.71 | 1.48M |
| 2024-01-02 | Nolan Sean P. | Buy | 1.18M | — | — |
| 2024-01-02 | Nolan Sean P. | Buy | 1.18M | $1.71 | 2.03M |
| 2023-12-14 | Alam Kamran | Buy | 187.58K | $0.70 | 131.10K |
| 2023-12-14 | Nagendran Sukumar | Buy | 334.00K | $0.70 | 233.44K |
| 2023-12-14 | Nolan Sean P. | Buy | 466.55K | $0.70 | 326.07K |
| 2023-11-17 | Manning Paul B | Buy | 100.00K | $1.63 | 163.00K |
| 2023-11-01 | Long Alison S | Buy | 43.80K | $2.38 | 104.46K |
| 2023-11-01 | Long Alison S | Other | 0 | — | — |
| 2023-08-24 | Alam Kamran | Sell | 33.00K | $2.33 | 76.89K |
| 2023-08-16 | Manning Paul B | Buy | 16.47M | $0.90 | 14.82M |
| 2023-08-16 | Stalfort John A III | Buy | 50.00K | — | — |
| 2023-08-16 | Stalfort John A III | Buy | 388.89K | $0.90 | 350.00K |
| 2023-08-16 | Stalfort John A III | Buy | 388.89K | $0.90 | 350.00K |
| 2023-08-16 | Nolan Sean P. | Buy | 444.44K | $0.90 | 400.00K |
| 2023-08-16 | Donenberg Phillip B. | Buy | 111.11K | $0.90 | 100.00K |
| 2023-07-13 | Session R.A. II | Sell | 5.34K | $0.70 | 3.74K |
| 2023-07-12 | Session R.A. II | Sell | 80.53K | $0.71 | 57.03K |
| 2023-06-23 | Session R.A. II | Sell | 18.10K | $0.70 | 12.74K |
| 2023-06-22 | Sepp-Lorenzino Laura | Buy | 36.20K | $0.72 | 26.06K |
| 2023-06-22 | Reape Kathleen | Buy | 36.20K | $0.72 | 26.06K |
| 2023-06-22 | Donenberg Phillip B. | Buy | 36.20K | $0.72 | 26.06K |
| 2023-06-22 | Stalfort John A III | Buy | 43.80K | $0.72 | 31.54K |
| 2023-06-22 | Stalfort John A III | Sell | 0 | — | — |
| 2023-06-22 | Stalfort John A III | Other | 0 | — | — |
| 2023-06-22 | Session R.A. II | Sell | 10.51K | $0.70 | 7.38K |
| 2023-06-21 | Session R.A. II | Sell | 138.96K | $0.70 | 97.63K |
| 2023-06-20 | Session R.A. II | Sell | 295.65K | $0.71 | 210.21K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 216, holders +20 vs prior quarter. Ownership 81.77%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 23.89M | 2.19M | +10.09% | 162.68M |
| RA CAPITAL MANAGEMENT, L.P. | 23.56M | 0 | 0.00% | 160.41M |
| GOLDMAN SACHS GROUP INC | 22.71M | 343.47K | +1.54% | 154.68M |
| BLACKROCK, INC. | 20.69M | 2.33M | +12.67% | 140.91M |
| VESTAL POINT CAPITAL, LP | 19.41M | 1.42M | +7.86% | 132.22M |
| MORGAN STANLEY | 16.49M | -1.48M | -8.23% | 112.28M |
| RTW INVESTMENTS, LP | 13.56M | -119.99K | -0.88% | 92.35M |
| FMR LLC | 13.34M | -984.84K | -6.88% | 90.82M |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.48M | 2.25M | +21.96% | 84.98M |
| STATE STREET CORP | 11.42M | 212.84K | +1.90% | 77.78M |
| SIREN, L.L.C. | 9.85M | 1.02M | +11.51% | 67.06M |
| OCTAGON CAPITAL ADVISORS LP | 9.69M | 833.33K | +9.41% | 66.01M |
| GEODE CAPITAL MANAGEMENT, LLC | 6.56M | 1.03M | +18.59% | 44.69M |
| POLAR CAPITAL HOLDINGS PLC | 5.12M | -537.21K | -9.50% | 34.85M |
| MPM BIOIMPACT LLC | 4.50M | 4.50M | New | 30.64M |
| D. E. SHAW & CO., INC. | 4.40M | -28.65K | -0.65% | 29.95M |
| BAKER BROS. ADVISORS LP | 4.00M | 0 | 0.00% | 27.27M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.98M | 3.35M | +534.71% | 27.07M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.89M | 1.00M | +34.76% | 26.46M |
| GORDONMD GLOBAL INVESTMENTS LP | 723.18K | -14.37K | -1.95% | 24.50M |
| CASDIN CAPITAL, LLC | 3.25M | 0 | 0.00% | 22.13M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.14M | 1.12M | +55.25% | 21.38M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 3.04M | 61.04K | +2.05% | 20.71M |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.77M | 2.77M | New | 18.87M |
| ABERDEEN GROUP PLC | 2.33M | 1.31M | +127.91% | 15.85M |
Earnings and financials
Taysha Gene Therapies, Inc. (TSHA) trades at $4.26, with a market cap of $1.38B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn